Stay updated on Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer’s site revision number changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the previous study content. This blocks access to the study details on that page.SummaryDifference19%

- Check31 days agoChange DetectedThe page's revision label updated from v3.6.6 to v3.7.0, indicating a software version update.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page footer now displays Revision: v3.6.6 instead of v3.6.5, indicating a new build deployment.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor site update with no changes to study information or user-facing content.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a new page build. This reflects a minor maintenance update to the page's version identifier.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.